[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100606337":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":26,"locations":36,"responsibleParty":52,"collaborators":10,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":10,"eligibilityCriteria":60,"healthyVolunteers":56,"sex":61,"minAge":62,"maxAge":10,"enrollmentInfo":63,"targetDuration":10,"studyType":66,"phases":10,"briefSummary":67,"conditions":68,"keywords":70,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"Icahn School of Medicine at Mount Sinai","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Participants with Gestational diabetes GDM",null,"All participants who wear CGM and have their postpartum OGTT",[13],"Device: continuous glucose monitor",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","continuous glucose monitor","All participants who wear CGM",[9],[21],"CGM",[23],{"name":24,"affiliation":5,"role":25},"Grenye O'Malley, MD","PRINCIPAL_INVESTIGATOR",[27,32],{"name":28,"role":29,"phone":30,"phoneExt":10,"email":31},"Sarah Rancic","CONTACT","212-241-5355","sarah.rancic@mssm.edu",{"name":33,"role":29,"phone":34,"phoneExt":10,"email":35},"Grenye O'Malley","212-241-7173","grenye.o'malley@mssm.edu",[37],{"facility":5,"status":38,"city":39,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"RECRUITING","New York","10029","United States","US",{"type":44,"coordinates":45},"Point",[46,47],-74.00597,40.71427,{"lat":47,"lon":46},[50,51],{"name":28,"role":29,"phone":30,"phoneExt":10,"email":31},{"name":33,"role":25,"phone":10,"phoneExt":10,"email":10},{"type":25,"investigatorFullName":33,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Associate Professor","100606337","pregnancy-and-postpartum-cgm-in-gdm-100606337",false,"NCT07174245","Pregnancy and Postpartum CGM in GDM","Pregnancy and Postpartum Continuous Glucose Monitoring in Gestational Diabetes","Inclusion Criteria:\n\n* Diagnosis of gestational diabetes during current pregnancy\n* age 18 or older\n* prescribed Dexcom G7\n\nExclusion Criteria:\n\n* Pregestational diabetes\n* known skin adhesive allergy which inhibits ongoing use of CGM\n* chronic oral steroid use.","FEMALE","18 Years",{"count":64,"type":65},40,"ESTIMATED","OBSERVATIONAL","Gestational diabetes (GDM) is one of the most common complications of pregnancy, and up to one third of women with GDM will have abnormal blood sugars after their pregnancy. To screen for abnormal blood sugars, standard of care is a 4-12 week postpartum oral glucose tolerance test (OGTT). However only 17-60% of women actually have this test performed. This study is to assess continuous glucose monitor data from the third trimester and up to 14 days postpartum to find predictors of postpartum OGTT results.",[69],"Gestational Diabetes",[71,17,72,73],"gestational diabetes","glucose sensor","oral glucose tolerance test","2026-07-06",{"date":76,"type":77},"2026-07-08","ACTUAL",{"date":79,"type":77},"2025-08-05",{"date":81,"type":65},"2027-07-01",{"name":5,"class":6},1]